(Q28550641)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26959239%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

image

Tolerability and Pharmacokinetic Evaluation of Inhaled Dry Powder Tobramycin Free Base in Non-Cystic Fibrosis Bronchiectasis Patients.pdf
1,275 × 1,650, 12 pages; 768 KB

0 references

title

Tolerability and Pharmacokinetic Evaluation of Inhaled Dry Powder Tobramycin Free Base in Non-Cystic Fibrosis Bronchiectasis Patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26959239%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

0 references

1 reference

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26959239%20AND%20SRC:MED&resulttype=core&format=json

Hubertus Adrianus Marie Kerstjens

10 March 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26959239%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Henderik W Frijlink

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26959239%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

author name string

Marcel Hoppentocht

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26959239%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Onno W Akkerman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26959239%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Paul Hagedoorn

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26959239%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Jan-Willem C Alffenaar

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26959239%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Anne H de Boer

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26959239%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

language of work or name

English

0 references

publication date

9 March 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26959239%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26959239%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26959239%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26959239%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

page(s)

e0149768

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26959239%20AND%20SRC:MED&resulttype=core&format=json

document file on Wikimedia Commons

10 March 2020

Tolerability and Pharmacokinetic Evaluation of Inhaled Dry Powder Tobramycin Free Base in Non-Cystic Fibrosis Bronchiectasis Patients.pdf
1,275 × 1,650, 12 pages; 768 KB

0 references

copyright license

Creative Commons Attribution 4.0 International

start time

9 March 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Evidence of inhaled tobramycin in non-cystic fibrosis bronchiectasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784940

Developments and strategies for inhaled antibiotic drugs in tuberculosis therapy: a critical evaluation.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784940

The particle has landed--characterizing the fate of inhaled pharmaceuticals

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784940

Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784940

Tobramycin inhalation powder for P. aeruginosa infection in cystic fibrosis: the EVOLVE trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784940

Immunomodulatory effects of macrolide antibiotics - part 1: biological mechanisms.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784940

British Thoracic Society guideline for non-CF bronchiectasis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784940

A pilot study of the safety and efficacy of tobramycin solution for inhalation in patients with severe bronchiectasis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784940

Effect of nebulized colistin sulphate and colistin sulphomethate on lung function in patients with cystic fibrosis: a pilot study.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784940

Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784940

Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784940

Effects of airway infection by Pseudomonas aeruginosa: a computed tomographic study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784940

Clinical, pathophysiologic, and microbiologic characterization of bronchiectasis in an aging cohort

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784940

The Concentration of Tobramycin in Bronchial Secretions

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784940

The Cyclops for pulmonary delivery of aminoglycosides; a new member of the Twincer™ family.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784940

Novel tobramycin inhalation powder in cystic fibrosis subjects: pharmacokinetics and safety

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784940

Long-term effects of inhaled tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784940

MW/Pharm, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoring

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784940

Bronchiectasis: an update.

3 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0149768

Effect of sputum bacteriology on the quality of life of patients with bronchiectasis.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0149768

Penetration of gentamicin into the alveolar lining fluid of critically ill patients with ventilator-associated pneumonia.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784940

Inhalation of a dry powder tobramycin PulmoSphere formulation in healthy volunteers

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784940

Safety of aerosol tobramycin administration for 3 months to patients with cystic fibrosis

27 November 2018

1 reference

12 December 2020

Long-term tobramycin aerosol therapy in cystic fibrosis

1 reference

12 December 2020

Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis

1 reference

12 December 2020

Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis

1 reference

12 December 2020

The Effect of Pseudomonas aeruginosa Infection on Clinical Parameters in Steady-State Bronchiectasis

1 reference

12 December 2020

Correlation of CT findings with clinical evaluations in 261 patients with symptomatic bronchiectasis

1 reference

12 December 2020

1 reference

12 December 2020

Bronchial inflammation and colonization in patients with clinically stable bronchiectasis

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0149768

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26959239%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

0 references

release_6gh7spe6hfdujfn6c7xrlunwzm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6gh7spe6hfdujfn6c7xrlunwzm

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26959239%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

PubMed publication ID

26959239

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26959239%20AND%20SRC:MED&resulttype=core&format=json